Protagenic Therapeutics, Inc.\new Interest Expense
Protagenic Therapeutics, Inc.\new (PTIX) reported Interest Expense of $107.68 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-05-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-15
- Protagenic Therapeutics, Inc.\new interest expense for the quarter ending 2023-12-31 was $12.85K, a 59.78% decline year-over-year.
- Protagenic Therapeutics, Inc.\new interest expense for the quarter ending 2023-09-30 was $31.96K, a 0.00% change year-over-year.
- Protagenic Therapeutics, Inc.\new interest expense for the quarter ending 2023-06-30 was $31.61K, a 20.37% decline year-over-year.
- Protagenic Therapeutics, Inc.\new interest expense for the quarter ending 2023-03-31 was $31.26K, a 7.63% decline year-over-year.
- Protagenic Therapeutics, Inc.\new interest expense for fiscal 2023 was $107.68K, a 21.66% decline from fiscal 2022.
- Protagenic Therapeutics, Inc.\new interest expense for fiscal 2022 was $137.46K, a 72.34% decline from fiscal 2021.
- Protagenic Therapeutics, Inc.\new interest expense for fiscal 2021 was $496.91K, a 101.85% increase from fiscal 2020.
- Protagenic Therapeutics, Inc.\new interest expense for fiscal 2020 was $246.18K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $12.85K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $44.81K derived: sum of 2 quarters · filed 2024-05-14 | $76.42K derived: sum of 3 quarters · filed 2024-05-14 | $107.68K 10-K/A · filed 2024-05-14 | ||
| 2023-09-30 | $31.96K 10-Q · filed 2023-11-14 | $63.57K derived: sum of 2 quarters · filed 2023-11-14 | $94.83K 10-Q · filed 2023-11-14 | $126.79K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-06-30 | $31.61K 10-Q · filed 2023-08-14 | $62.87K 10-Q · filed 2023-08-14 | $94.83K derived: sum of 3 quarters · filed 2024-05-15 | $126.79K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-03-31 | $31.26K 10-Q · filed 2024-05-15 | $63.22K derived: sum of 2 quarters · filed 2024-05-15 | $95.18K derived: sum of 3 quarters · filed 2024-05-15 | $134.88K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $31.96K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $63.91K derived: sum of 2 quarters · filed 2024-05-14 | $103.61K derived: sum of 3 quarters · filed 2024-05-14 | $137.46K 10-K/A · filed 2024-05-14 | ||
| 2022-09-30 | $31.96K 10-Q · filed 2023-11-14 | $71.65K derived: sum of 2 quarters · filed 2023-11-14 | $105.50K 10-Q · filed 2023-11-14 | $164.82K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $39.70K 10-Q · filed 2023-08-14 | $73.54K 10-Q · filed 2023-08-14 | $132.86K derived: sum of 3 quarters · filed 2023-08-14 | $247.33K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $33.84K 10-Q · filed 2023-05-15 | $93.17K derived: sum of 2 quarters · filed 2023-05-15 | $207.63K derived: sum of 3 quarters · filed 2023-05-15 | $446.82K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $59.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $173.78K derived: sum of 2 quarters · filed 2023-03-31 | $412.98K derived: sum of 3 quarters · filed 2023-03-31 | $496.91K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $114.46K 10-Q · filed 2022-11-14 | $353.65K derived: sum of 2 quarters · filed 2022-11-14 | $437.59K 10-Q · filed 2022-11-14 | $531.01K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $239.19K 10-Q · filed 2022-08-11 | $323.13K 10-Q · filed 2022-08-11 | $416.55K derived: sum of 3 quarters · filed 2022-08-11 | $475.38K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $83.94K 10-Q · filed 2022-05-13 | $177.36K derived: sum of 2 quarters · filed 2022-05-13 | $236.19K derived: sum of 3 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $93.42K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $152.25K derived: sum of 2 quarters · filed 2022-04-07 | $246.18K 10-K · filed 2022-04-07 | |||
| 2020-09-30 | $58.83K 10-Q · filed 2021-11-15 | $152.76K 10-Q · filed 2021-11-15 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $1.77K derived: sum of 3 quarters · filed 2018-04-02 | $7.16K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $1.77K derived: sum of 2 quarters · filed 2017-11-13 | $7.16K 10-Q · filed 2017-11-13 | $7.16K 10-Q · filed 2016-11-17 | $15.16K derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $1.77K 10-Q · filed 2017-08-08 | $7.16K 10-Q · filed 2017-08-08 | $7.16K 10-Q · filed 2016-08-15 | $15.16K derived: sum of 3 quarters · filed 2017-08-08 | $22.16K derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $5.39K 10-Q · filed 2017-05-15 | $13.39K derived: sum of 2 quarters · filed 2017-05-15 | $20.39K derived: sum of 3 quarters · filed 2017-05-15 | $26.39K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $8.00K 10-Q · filed 2016-03-11 | $15.00K 10-Q · filed 2016-03-11 | $21.00K derived: sum of 3 quarters · filed 2016-03-11 | $11.47K 10-K/A · filed 2017-05-08 | ||
| 2015-09-30 | $7.00K 10-Q · filed 2015-11-13 | $13.00K derived: sum of 2 quarters · filed 2015-11-13 | $19.00K derived: sum of 3 quarters · filed 2015-11-13 | $23.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2015-06-30 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $12.00K derived: sum of 2 quarters · filed 2015-09-25 | $16.00K derived: sum of 3 quarters · filed 2016-03-11 | $18.00K 10-K · filed 2015-09-25 | ||
| 2015-03-31 | $6.00K 10-Q · filed 2015-05-11 | $10.00K derived: sum of 2 quarters · filed 2016-03-11 | $12.00K 10-Q · filed 2015-05-11 | $15.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-12-31 | $4.00K 10-Q · filed 2016-03-11 | $6.00K 10-Q · filed 2016-03-11 | $9.00K derived: sum of 3 quarters · filed 2016-03-11 | $10.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-09-30 | $3.00K 10-Q · filed 2015-11-13 | $5.00K derived: sum of 2 quarters · filed 2015-11-13 | $6.00K derived: sum of 3 quarters · filed 2015-11-13 | $6.00K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $3.00K derived: sum of 2 quarters · filed 2015-09-25 | $3.00K derived: sum of 3 quarters · filed 2015-09-25 | $3.00K 10-K · filed 2015-09-25 | ||
| 2014-03-31 | $1.00K 10-Q · filed 2015-05-11 | $1.00K derived: sum of 2 quarters · filed 2015-05-11 | $1.00K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | |||||
| 2011-06-30 | $1.17M 10-Q/A · filed 2011-09-07 | $1.17M 10-Q/A · filed 2011-09-07 | ||||
| 2010-06-30 | $1.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |